Form 4: Medpace Executive Plans Future Stock Option Exercise

Medpace Holdings, Inc. Executive Vice President of Operations, Susan E. Burwig, filed a Form 4 indicating a planned exercise of 10,000 stock options in August 2025.

Summary

• Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc. (MEDP), filed a Form 4 disclosing a planned transaction.
• The filing indicates a future exercise of 10,000 employee stock options into common stock on August 26, 2025.
• The exercise price for these options is $107.93 per share.
• Following this planned transaction, Ms. Burwig will beneficially own 67,500 shares of common stock directly.
• The options that are planned to be exercised vested in full on February 28, 2020, and have an expiration date of February 28, 2026.
• After the planned exercise, Ms. Burwig will hold 40,984 derivative securities (employee stock options) beneficially owned directly.

Sentiment

Score: 6

Explanation: The filing details a routine, pre-planned exercise of stock options by an executive. This is a neutral to slightly positive event, as it reflects an executive managing their equity compensation rather than a direct signal of company performance or a significant change in insider sentiment.

Positives

• The transaction is a planned exercise of vested employee stock options, often indicative of an executive managing their equity compensation.
• The filing notes the transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, likely a Rule 10b5-1(c) plan, which promotes orderly and pre-scheduled insider transactions.

Future Outlook

The filing details a pre-planned future transaction for an executive to exercise stock options on August 26, 2025, indicating a scheduled management of equity compensation.

Industry Context

This filing represents a routine disclosure of an insider's planned equity transaction, common across publicly traded companies as executives manage their compensation and holdings. The use of a 10b5-1 plan is a standard practice for executives to trade company stock in a pre-arranged, compliant manner.

Corporate Governance

Related Party Transactions

• The exercise of employee stock options by an Executive Vice President is inherently a related party transaction, as it involves a key management personnel and the company's equity.

Stakeholder Impact

• Shareholders: The exercise will result in a minor increase in the number of outstanding shares, which is a routine dilution effect from equity compensation plans.
• Employees: The transaction demonstrates an executive utilizing their equity compensation, which can be a positive signal regarding the value of employee stock options.

Next Steps

• The actual execution of the option exercise transaction on August 26, 2025.

Key Dates

Recommendation

This Form 4 details a pre-planned, future exercise of employee stock options by an executive. Such routine transactions, often executed under 10b5-1 plans, are generally not considered a significant catalyst for immediate stock price movement or a change in investment thesis. It reflects an executive managing their equity compensation rather than a strong directional signal for the company's future performance.

Keywords

Medpace Holdings, MEDP, Form 4, insider transaction, stock option exercise, Susan E. Burwig, executive compensation, 10b5-1 plan